AI定制狗癌疫苗公司Gamgee获400万美元融资
一篇关于AI个性化癌症疫苗从个人自救走向创业公司的故事，核心是解决疫苗生产速度和成本问题。
澳洲AI工程师Paul Conyngham为救患癌爱犬，自学基因组学并借助AI设计个性化mRNA疫苗，使肿瘤缩小75%，但因疫苗生产速度不够快，爱犬最终离世。他随后创立Gamgee，将这一过程工业化，目标48小时内完成疫苗设计、疗程成本降至2000美元，并已获Founders Fund领投的400万美元种子轮融资。
正文摘录
 AI Era 报道  Remember the viral "real-life Version of the Drug God" story that swept the internet a few months ago? An Australian AI expert with zero professional medical background, determined to save his cancer-stricken dog, taught himself genomics and literally hand-built the world's first bespoke mRNA cancer vaccine. One injection later, the tennis-ball-sized tumor on his dog's leg miraculously shrank by 75%, buying her precious extra time.  However, the latest chapter of this story ends with a heart-wrenching twist. Just today, Paul Conyngham announced heartb…